Already a Bloomberg.com user?
Sign in with the same account.
SINPHAR PHARMA said unconsolidated sales in May rose 27.33% to NT$163,445,000 from NT$128,363,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
5/2012 5/2011 Sales 163,445 128,363 YOY% 27.33%
-----------------Year-to-date----------------- Sales 702,323 674,625 YOY% 4.11% =================================================================